A detailed history of Raymond James & Associates transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Raymond James & Associates holds 140,982 shares of DGX stock, worth $19.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
140,982
Previous 126,083 11.82%
Holding current value
$19.3 Million
Previous $17.3 Million 11.99%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$137.09 - $137.09 $2.04 Million - $2.04 Million
14,899 Added 11.82%
140,982 $19.3 Million
Q2 2024

Jul 19, 2024

SELL
$125.91 - $144.34 $5.87 Million - $6.73 Million
-46,602 Reduced 26.99%
126,083 $17.3 Million
Q1 2024

Apr 22, 2024

BUY
$123.78 - $142.11 $3.02 Million - $3.47 Million
24,434 Added 16.48%
172,685 $23 Million
Q4 2023

Jan 16, 2024

BUY
$120.62 - $141.12 $9.08 Million - $10.6 Million
75,315 Added 103.26%
148,251 $20.4 Million
Q3 2023

Oct 24, 2023

BUY
$121.86 - $144.92 $22,178 - $26,375
182 Added 0.25%
72,936 $8.89 Million
Q2 2023

Jul 25, 2023

SELL
$130.56 - $146.84 $126,251 - $141,994
-967 Reduced 1.31%
72,754 $10.2 Million
Q1 2023

Apr 14, 2023

SELL
$131.53 - $155.76 $1.32 Million - $1.56 Million
-10,042 Reduced 11.99%
73,721 $10.4 Million
Q4 2022

Feb 08, 2023

BUY
$123.31 - $157.26 $569,075 - $725,754
4,615 Added 5.83%
83,763 $13.1 Million
Q3 2022

Oct 25, 2022

BUY
$121.77 - $141.1 $388,446 - $450,109
3,190 Added 4.2%
79,148 $9.71 Million
Q2 2022

Aug 12, 2022

BUY
$127.07 - $145.39 $303,570 - $347,336
2,389 Added 3.25%
75,958 $10.1 Million
Q1 2022

May 11, 2022

SELL
$129.09 - $164.35 $823,594 - $1.05 Million
-6,380 Reduced 7.98%
73,569 $10.1 Million
Q4 2021

Feb 08, 2022

SELL
$140.36 - $173.01 $6.34 Million - $7.81 Million
-45,154 Reduced 36.09%
79,949 $13.8 Million
Q3 2021

Nov 02, 2021

SELL
$132.95 - $158.0 $2.99 Million - $3.56 Million
-22,516 Reduced 15.25%
125,103 $18.2 Million
Q2 2021

Aug 11, 2021

SELL
$126.66 - $141.48 $2.46 Million - $2.75 Million
-19,412 Reduced 11.62%
147,619 $19.5 Million
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $442,815 - $515,092
-3,863 Reduced 2.26%
167,031 $21.4 Million
Q4 2020

Feb 12, 2021

SELL
$112.7 - $128.05 $4.14 Million - $4.7 Million
-36,704 Reduced 17.68%
170,894 $20.4 Million
Q3 2020

Nov 04, 2020

BUY
$107.05 - $130.01 $1.6 Million - $1.94 Million
14,913 Added 7.74%
207,598 $23.8 Million
Q2 2020

Jul 28, 2020

BUY
$73.34 - $122.61 $597,647 - $999,148
8,149 Added 4.42%
192,685 $22 Million
Q1 2020

Apr 21, 2020

BUY
$75.14 - $115.68 $8.33 Million - $12.8 Million
110,926 Added 150.69%
184,536 $14.8 Million
Q4 2019

Feb 12, 2020

SELL
$100.29 - $107.99 $2.93 Million - $3.15 Million
-29,177 Reduced 28.39%
73,610 $7.86 Million
Q3 2019

Nov 07, 2019

SELL
$97.85 - $107.42 $2.16 Million - $2.37 Million
-22,050 Reduced 17.66%
102,787 $11 Million
Q2 2019

Aug 06, 2019

BUY
$85.18 - $101.94 $1.33 Million - $1.59 Million
15,645 Added 14.33%
124,837 $12.7 Million
Q1 2019

May 06, 2019

BUY
$80.68 - $89.92 $5.64 Million - $6.29 Million
69,918 Added 178.03%
109,192 $9.82 Million
Q4 2018

Feb 11, 2019

BUY
$79.75 - $108.38 $974,066 - $1.32 Million
12,214 Added 45.14%
39,274 $3.27 Million
Q3 2018

Nov 14, 2018

SELL
$105.42 - $114.99 $37,740 - $41,166
-358 Reduced 1.31%
27,060 $2.92 Million
Q2 2018

Aug 14, 2018

BUY
$97.35 - $113.14 $200,833 - $233,407
2,063 Added 8.14%
27,418 $3.01 Million
Q1 2018

May 14, 2018

SELL
$96.42 - $107.88 $436,011 - $487,833
-4,522 Reduced 15.14%
25,355 $2.54 Million
Q4 2017

Feb 14, 2018

SELL
$90.86 - $100.24 $1.13 Million - $1.24 Million
-12,387 Reduced 29.31%
29,877 $2.94 Million
Q3 2017

Nov 13, 2017

SELL
$91.96 - $108.35 $33,657 - $39,656
-366 Reduced 0.86%
42,264 $3.96 Million
Q2 2017

Aug 14, 2017

BUY
N/A
42,630
42,630 $4.74 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.